Evaluation of a near-patient SARS-CoV-2 novel rapid diagnostic platform
Microbiology Spectrum · 2024
DOI: 10.1128/spectrum.00672-24 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Johannes C Botha und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection, Immunity and Inflammation, Institute of Child Health, University College London, London, United Kingdom. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Nucleic Acid Amplification Techniques, Molecular Diagnostic Techniques. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The goal of this study is to test a novel device and methodology based on the “Pebble” platform and real-time quantitative colorimetric loop-mediated isothermal amplification (qcLAMP) during SARS-CoV-2 detection using crude samples and extracted RNA. The new method employs an inexpensive lightweight device aimed toward rapid point-of-care testing. An extensive evaluation was performed consisting of 1,693 clinical samples across five independent clinical testing centers. Positive colorimetric results were observed within 20 minutes of testing. At a 20-minute time-to-positive cut-off, the specificity is 98.5% with a diagnostic accuracy of 91.9%, compared to qPCR assays. Our findings indicate that the SARS-CoV-2 qcLAMP diagnostic assay in conjunction with the Pebble device is ideal for point-of-care/near-patient testing. IMPORTANCE Here, we describe our analyses and validation of a novel real-time quantitative colorimetric loop-mediated isothermal amplification (qcLAMP) device, available under the name “Pebble” and associated SARS-CoV-2 diagnostic qcLAMP assay for clinical diagnostic use. The analyses were performed in five independent testing sites across Europe using clinical samples from the associated clinical sites and support the use of “pebble” and associated kit in the diagnostic environment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infection, Immunity and Inflammation, Institute of Child Health, University College London, London, United Kingdom.
- University College London Hospitals NHS Trust, Advanced Pathogen Diagnostics Unit, London, United Kingdom.
- Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Laboratoire de Virologie, Paris, France.
- Department of Microbiology, Laboratoire Hospitalier Universitaire de Bruxelles-Universitair Laboratorium Brussel (LHUB-ULB), Université Libre de Bruxelles, Brussels, Belgium.
- Department of Microbiology, AHEPA University Hospital, Medical School Aristotle University of Thessaloniki, Thessaloniki, Greece.
- BIOPIX DNA TECHNOLOGY PC, Science and Technology Park of Crete, Heraklion, Greece.
ORCID-Profile: Johannes C Botha, Nicolas Yin, Olivier Vandenberg, Eleni Nastouli
Zitieren
APA
Botha, J. C., Zafilaza, K., Soulie, C., Yin, N., Spyer, M., Balaska, S., Chatziioannidou, S., Tsiakalou, V., Papadakis, G., Skoura, L., Zafiropoulos, A., Sourvinos, G., Vandenberg, O., Marcelin, A. G., Gizeli, E., & Nastouli, E. (2024). Evaluation of a near-patient SARS-CoV-2 novel rapid diagnostic platform. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00672-24
Vancouver
Botha JC, Zafilaza K, Soulie C, Yin N, Spyer M, Balaska S, et al. Evaluation of a near-patient SARS-CoV-2 novel rapid diagnostic platform. Microbiology Spectrum. 2024. doi:10.1128/spectrum.00672-24
BibTeX
@article{Botha2024,
author = {Botha, Johannes C and Zafilaza, Karen and Soulie, Cathia and Yin, Nicolas and Spyer, Moira and Balaska, Sofia and Chatziioannidou, Stella and Tsiakalou, Vaia and Papadakis, George and Skoura, Lemonia and Zafiropoulos, Alexandros and Sourvinos, George and Vandenberg, Olivier and Marcelin, Anne-Geneviève and Gizeli, Electra and Nastouli, Eleni},
title = {Evaluation of a near-patient SARS-CoV-2 novel rapid diagnostic platform},
journal = {Microbiology Spectrum},
year = {2024},
doi = {10.1128/spectrum.00672-24}
}
EUVIMED